Crossmark

Exercise training decreases Neuregulin-1 concentrations in HER2-positive breast cancer patients undergoing adjuvant trastuzumab: the CARDAPAC study

Published Online: 2026-02-04

Published Print: 2026-02

Authors

Jacquinot, Quentin

Ennequin, Gaël

Falcoz, Antoine

Sawyer, Douglas

Meneveau, Nathalie

Mougin, Fabienne
License Information

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2026-02-01
More Information

Article History

Received: 29 July 2025

Accepted: 26 January 2026

First Online: 4 February 2026

Declarations

:

: The authors declare no competing interests.

: The study was approved by the French National Health Products Safety Agency (P/2014/241) and this trial was registered on the National Clinical Trials under the number NCT02433067.

Document is current